Clinical Trials on Ischemic Leg
Total 0 results
Nothing found
Sponsors and Collaborators
- The Third Hospital of Changsha
- CTC Bio, Inc.
- Kawin Technology Share-holding Co., Ltd.
- Rex Bionics Plc
- Montreal Neurological Institute and Hospital
- Health Parametrics Inc.
- Jeffrey W. Clark, MD
- New York State Health Foundation
- MingSight Pharmaceuticals Pty Limited
- Northern California Melanoma Center
- Zahra Rabbani Khah
- European Network For Smoking and Tobacco Prevention
- Marilia Medicine School
- Honda R and D Americas, Inc.
- Ionis Pharmaceuticals
- Medtronic Atrial Fibrillation Solutions
- Mitchell Scheiman
- Jeffrey Rudolph
- John Granton
- Wushan County People's Hospital
- View Full List
Medical Conditions
- Low Birthweight, Extremely (999 Grams or Less)
- Influenza and Other Novel Respiratory Viruses
- Postmenopausal Diabetes
- Pertussis Immunisation
- Myeloproliferative Disease
- Periodontology
- Heart Defect, Congenital
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Idiopathic Gastric Stasis
- Fecal Elastase-1 Test
- Acute Necrotizing Encephalopathy
- Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social Pressure.
- Canthal Lines
- Improved Vocal Fold Status
- Moderate to Severe Functional Impairments
- Pediatric Anaplastic Large Cell Lymphoma
- Ketamine Treatment
- Suspected Neonatal Encephalopathy
- Radial Artery Catheterization
- Nutritional Edema
- View Full List
Drug Interventions
- CKD-519
- AZD7798
- Levobupivacaine, clonidine
- Bendamustine
- Postoperative analgesia management
- Nimotuzumab
- Ombrabulin (AVE8062)
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- Rifaximin
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Hydroxychloroquine
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- ESK981
- Fludarabine
- Pentostatin
- Levcromakalim
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Toripalimab plus Anlotinib
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- 200 µg doxorubicin-containing MNA
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Belgium
- Contract Research Organizations in Benin
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Germany
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Morocco
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Qatar
- Contract Research Organizations in South Africa
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Ukraine
- CRO list by country